Navigation Links
Oramed to Participate in Barclays' Israel Biotech Corporate Day in Zurich on September 30, 2013
Date:9/25/2013

JERUSALEM, September 25, 2013 /PRNewswire/ --

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that it has been invited to participate in an exclusive Israeli Biotech Corporate Day, hosted by Barclays on September 30, 2013 in Zurich, Switzerland.  The event is designed to connect prominent Israeli biotech companies with Barclays' investors for future potential collaborations.  

"We are pleased to be invited to this unique event and look forward to connecting with the European investment community," stated Oramed CEO Nadav Kidron.

About Oramed Pharmaceuticals

Oramed Pharmaceuticals is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently initiating Phase 2 clinical trials on patients with type 2 diabetes (T2DM) under an Investigational New Drug application with the U.S. Food and Drug Administration, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), with trials on healthy volunteers (Phase 1b) and T2DM patients (Phase 2a) underway. Oramed is also moving forward with clinical trials of ORMD-0801 for the treatment of type 1 diabetes. The company's corporate and R&D headquarters are based in Jerusalem.

For more information, the content of which is not
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Oramed Submits Pre-IND Package to FDA for ORMD-0901 (oral exenatide), an Oral GLP-1 Analog for the Treatment of Type 2 Diabetes
2. Oramed CEO to be Panelist at BIO International Convention Breakout Session on Israel Becoming Biotech Leader
3. Oramed Pharmaceuticals Moves Forward with Investigational New Drug Application for Oral Insulin
4. Bioassociate Announces Initiation of Coverage on Oramed Pharmaceuticals, Inc.
5. Oramed Pharmaceuticals Announces Reverse Stock Split
6. Oramed Pharmaceuticals Granted 2nd Patent in New Zealand; 3rd Patent for Core Technology on Oral Delivery of Proteins
7. Proove Biosciences Will Participate at the California Society of Interventional Pain Physician’s 4th Annual Meeting This Weekend
8. 2013 to Be a Big Year for Biocompatibility; Nelson Labs Participates in Potential Updates
9. Rocky Mountain Biologicals CEO Selected to Participate in the 2013 Montana Economic Development Conference in Butte
10. ViroPharma To Participate In The Stifel Nicolaus 2013 Healthcare Conference
11. FDAs Lawrence Yu to Participate in Live Video Chat on Question-Based Review (QbR) for Generics on CPhI Pharma Evolution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... new study published today in the journal PNAS ... found that time of day and sleep deprivation have ... be crucial when looking at the best time of ... heart disease, and for administering medicines effectively. , Researchers ... Cancer Research, London, investigated the links between sleep deprivation, ...
(Date:7/10/2014)... out for crude 3-D glasses, polarized glasses, and ... basic devices, used to trick the brain into ... rendered obsolete with the introduction of new holography ... TAU doctoral students Yuval Yifat, Michal Eitan, and ... on nanoantennas that could be used for security ...
(Date:1/15/2014)...  Bill Jacobs Automotive, a group of car dealerships headquartered in ... Heartland Blood Center and offering free oil change coupons for ... Saturday, Jan. 18 at the Bill Jacobs Cadillac and Chevrolet ... http://photos.prnewswire.com/prnh/20140115/MN46637 )  The Bill Jacobs Auto ...
(Date:1/15/2014)... OXFORD, England and SAN JOSE, California ... an international biotechnology company developing antibody-drug conjugates for cancer, today ... its Board of Directors. Dr Reynolds has over 20 years, ... Chief Medical Officer at Seattle Genetics. "I am ...
Breaking Biology Technology:Time of day crucial to accurately test for diseases, new research finds 2Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Join the Bill Jacobs Auto blood drive and receive a free oil change 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... Purpose , ... of protease inhibitor (PI) and non-nucleoside reverse transcriptase inhibitor (NNRTI) ... of assessing inter-individual and intra-individual metabolism variability. To be of ... to monitor these drugs is fast and easy to perform, ...
... Introduction , ... products are radioactively labeled using either endlabeled primers or ... Successful sequencing results produced by these two labeling methods ... breaks, impurities or high secondary structure can cause DNA ...
... , Researchers and forensic agencies that test samples or ... These assays suffer from a number of limitations: , ... not as commonly available for novel sample matrices such as saliva as they are for ... be relatively costly due to the high volume of reagents used. , ...
Cached Biology Technology:A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 2A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 3A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 4A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase 2A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase 3Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 2Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 3Simultaneous Screening of 23 Drugs of Abuse in Oral Fluid Using an LC/MS/MS Method 4
(Date:7/10/2014)... known as heme enzymes, due to the presence of ... centre of the heme cofactor is an iron (Fe) ... is in an intermediate state called Compound I. The ... this oxidation involves just an oxygen atom (O), or ... implications for understanding oxidative processes within living cells, which ...
(Date:7/10/2014)... HOUSTON (July 10, 2014) New research from ... (UTHealth) shows that It,s Your GameKeep it Real (IYG), ... and promote healthy dating relationships, can significantly reduce dating ... Centers for Disease Control and Prevention, 10 percent of ... and other studies suggest that more than 20 percent ...
(Date:7/10/2014)... Spanish National Cancer Research Centre (CNIO) Macromolecular Crystallography ... a protein called BuD to DNA in order ... Montoya, the researcher who led the study, says ... edit the instructions contained in the genome to ... The study is published in the journal ...
Breaking Biology News(10 mins):Neutron crystallography solves long-standing biological mystery 2Neutron crystallography solves long-standing biological mystery 3It's Your Game ... Keep It Real reduces dating violence among minority youth 2CNIO scientists develop technology to redirect proteins towards specific areas of the genome 2
... Varanus komodoensis ) are known to bite prey and release ... the victims are reported to go into shock before the ... prey are killed by pathogenic bacteria in the dragons, mouths ... of Proceedings of the National Academy of Sciences ...
... active site found in a naturally occurring enzyme, chemists at ... like nature,s most pervasive hydrogen processor. , The researchers describe ... Journal of the American Chemical Society , and posted ... puzzled by nature,s ability to use cheap and plentiful building ...
... million cases of malaria are diagnosed each year mostly ... treat malaria do exist, the demand for new treatments ... have developed a resistance to existing medications. Now, ... have discovered one way to stop malaria parasite growth, ...
Cached Biology News:Komodo even more deadly than thought: Research 2New lead on malaria treatment 2
Reactivity: Human...
... Kit is designed for rapid preparation ... over commonly used transformation procedures such ... include:- Cells can be made competent in ... preparation and transformation solutions are optimized ...
...
... PCRx Enhancer System is ... polymerases to optimize PCR of ... 10X PCRX Enhancer Solution with ... higher primer specificity broader magnesium ...
Biology Products: